Ovid Therapeutics Inc. (OVID) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
OVID EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OVID Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 95.9% | -585.2% | -240.1% |
| 2024 | 100.0% | -10933.7% | -4670.1% |
| 2023 | 100.0% | -15122.7% | -13351.8% |
| 2022 | 100.0% | -3696.4% | -3604.7% |
| 2021 | 100.0% | 59.6% | 58.9% |
Download Data
Export OVID earnings history in CSV or JSON format
Free sign-in required to download data
Ovid Therapeutics Inc. (OVID) Earnings Overview
As of May 8, 2026, Ovid Therapeutics Inc. (OVID) reported trailing twelve-month net income of -$17M, reflecting +35.1% year-over-year growth. The company earned $-0.21 per diluted share over the past four quarters, with a net profit margin of -240.1%.
Looking at the long-term picture, OVID's historical earnings data spans multiple years. The company achieved its highest annual net income of $123M in fiscal 2021.
Ovid Therapeutics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), PRAX (-$327M net income), LGND ($49M net income, -2.4% margin), OVID has room to improve margins relative to the peer group. Compare OVID vs ACAD →
OVID Earnings vs Peers
Earnings metrics vs comparable public companies
OVID Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$17M | +34.1% | -$42M | $-0.24 | -240.1% | -585.2% |
| 2024 | -$26M | +49.5% | -$62M | $-0.37 | -4670.1% | -10933.7% |
| 2023 | -$52M | +3.4% | -$59M | $-0.74 | -13351.8% | -15122.7% |
| 2022 | -$54M | -144.1% | -$56M | $-0.77 | -3604.7% | -3696.4% |
| 2021 | $123M | +251.6% | $124M | $1.76 | 58.9% | 59.6% |
| 2020 | -$81M | -34.0% | -$81M | $-1.39 | -642.3% | -645.4% |
| 2019 | -$60M | -16.3% | -$61M | $-1.51 | - | - |
| 2018 | -$52M | +19.8% | -$53M | $-2.11 | - | - |
| 2017 | -$65M | -189.1% | -$65M | $-3.35 | - | - |
| 2016 | -$22M | -70.3% | -$23M | $-1.14 | - | - |
See OVID's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OVID Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OVID vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOVID — Frequently Asked Questions
Quick answers to the most common questions about buying OVID stock.
Is OVID growing earnings?
OVID EPS is $-0.21, with earnings growth accelerating to +35.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-17M.
What are OVID's profit margins?
Ovid Therapeutics Inc. net margin is -240.1%, with operating margin at -585.2%. Below-average margins reflect competitive or cost pressures.
How consistent are OVID's earnings?
OVID earnings data spans 2014-2025. The accelerating earnings trend is +35.1% YoY. Historical data enables comparison across business cycles.